|
1
|
Tomlinson GE and Kappler R: Genetics and
epigenetics of hepatoblastoma. Pediatr Blood Cancer. 59:785–92.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wu CH, Chiu NC, Yeh YC, Kuo Y, Yu SS, Weng
CY, Liu CA, Chou YH and Chiou YY: Uncommon liver tumors: Case
report and literature review. Medicine (Baltimore). 95:e49522016.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Folkman J: Angiogenesis. Annu Rev Med.
57:1–18. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Folkman J and Haudenschild C: Angiogenesis
in vitro. Nature. 288:551–556. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bry M, Kivelä R, Leppänen VM and Alitalo
K: Vascular endothelial growth factor-B in physiology and disease.
Physiol Rev. 94:779–794. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Folkman J: Tumor angiogenesis: Therapeutic
implications. N Engl J Med. 285:1182–1186. 1971. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dallas NA, Samuel S, Xia L, Fan F, Gray
MJ, Lim SJ and Ellis LM: Endoglin (CD105): A marker of tumor
vasculature and potential target for therapy. Clin Cancer Res.
14:1931–1937. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cheifetz S, Bellón T, Calés C, Vera S,
Bernabeu C, Massagué J and Letarte M: Endoglin is a component of
the transforming growth factor-beta receptor system in human
endothelial cells. J Biol Chem. 267:19027–19030. 1992.PubMed/NCBI
|
|
9
|
López-Novoa JM and Bernabeu C: The
physiological role of endoglin in the cardiovascular system. Am J
Physiol Heart Circ Physiol. 299:H959–H974. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nagatsuka H, Hibi K, Gunduz M, Tsujigiwa
H, Tamamura R, Sugahara T, Sasaki A and Nagai N: Various
immunostaining patterns of CD31, CD34 and endoglin and their
relationship with lymph node metastasis in oral squamous cell
carcinomas. J Oral Pathol Med. 34:70–76. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fonsatti E, Nicolay HJ, Altomonte M, Covre
A and Maio M: Targeting cancer vasculature via endoglin/CD105: A
novel antibody-based diagnostic and therapeutic strategy in solid
tumours. Cardiovasc Res. 86:12–19. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Duff SE, Li C, Garland JM and Kumar S:
CD105 is important for angiogenesis: Evidence and potential
applications. FASEB J. 17:984–992. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Miller DW, Graulich W, Karges B, Stahl S,
Ernst M, Ramaswamy A, Sedlacek HH, Müller R and Adamkiewicz J:
Elevated expression of endoglin, a component of the
TGF-beta-receptor complex, correlates with proliferation of tumor
endothelial cells. Int J Cancer. 81:568–572. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yang LY, Lu WQ, Huang GW and Wang W:
Correlation between CD105 expression and postoperative recurrence
and metastasis of hepatocellular carcinoma. BMC Cancer. 6:1102006.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Deshpande N, Needles A and Willmann JK:
Molecular ultrasound imaging: Current status and future directions.
Clin Radiol. 65:567–581. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Klibanov AL: Ligand-carrying gas-filled
microbubbles: Ultrasound contrast agents for targeted molecular
imaging. Bioconjug Chem. 16:9–17. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Abou-Elkacem L, Bachawal SV and Willmann
JK: Ultrasound molecular imaging: Moving toward clinical
translation. Eur J Radiol. 84:1685–1693. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Goodwin AP, Nakatsuka MA and Mattrey RF:
Stimulus-responsive ultrasound contrast agents for clinical
imaging: Motivations, demonstrations, and future directions. Wiley
Interdiscip Rev Nanomed Nanobiotechnol. 7:111–123. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Schmitz G: Ultrasonic imaging of molecular
targets. Basic Res Cardiol. 103:174–181. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Toaldo Baron M, Salvatore V, Marinelli S,
Palamà C, Milazzo M, Croci L, Venerandi L, Cipone M, Bolondi L and
Piscaglia F: Use of VEGFR-2 targeted ultrasound contrast agent for
the early evaluation of response to sorafenib in a mouse model of
hepatocellular carcinoma. Mol Imaging Biol. 17:29–37. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Streeter JE, Herrera-Loeza SG, Neel NF,
Yeh JJ and Dayton PA: A comparative evaluation of ultrasound
molecular imaging, perfusion imaging, and volume measurements in
evaluating response to therapy in patient-derived xenografts.
Technol Cancer Res Treat. 12:311–321. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sirsi SR, Flexman ML, Vlachos F, Huang J,
Hernandez SL, Kim HK, Johung TB, Gander JW, Reichstein AR, Lampl
BS, et al: Contrast ultrasound imaging for identification of early
responder tumor models to anti-angiogenic therapy. Ultrasound Med
Biol. 38:1019–1029. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Anderson CR, Hu X, Zhang H, Tlaxca J,
Declèves AE, Houghtaling R, Sharma K, Lawrence M, Ferrara KW and
Rychak JJ: Ultrasound molecular imaging of tumor angiogenesis with
an integrin targeted microbubble contrast agent. Invest Radiol.
46:215–224. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Deshpande N, Ren Y, Foygel K, Rosenberg J
and Willmann JK: Tumor angiogenic marker expression levels during
tumor growth: Longitudinal assessment with molecularly targeted
microbubbles and US imaging. Radiology. 258:804–811. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu H, Chen Y, Yan F, Han X, Wu J, Liu X
and Zheng H: Ultrasound molecular imaging of vascular endothelial
growth factor receptor 2 expression for endometrial receptivity
evaluation. Theranostics. 5:206–217. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang H, Li L, Wang Y, Dong F, Chen X, Liu
F, Xu D, Yi F, Kapron CM and Liu J: NF-κB signaling maintains the
survival of cadmium-exposed human renal glomerular endothelial
cells. Int J Mol Med. 38:417–422. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu J, Kanki Y, Okada Y, Jin E, Yano K,
Shih SC, Minami T and Aird WC: A +220 GATA motif mediates basal but
not endotoxin-repressible expression of the von Willebrand factor
promoter in Hprt-targeted transgenic mice. J Thromb Haemost.
7:1384–1392. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhu AX, Duda DG, Sahani DV and Jain RK:
HCC and angiogenesis: Possible targets and future directions. Nat
Rev Clin Oncol. 8:292–301. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Baek HJ, Lim SC, Kitisin K, Jogunoori W,
Tang Y, Marshall MB, Mishra B, Kim TH, Cho KH, Kim SS and Mishra L:
Hepatocellular cancer arises from loss of transforming growth
factor beta signaling adaptor protein embryonic liver fodrin
through abnormal angiogenesis. Hepatology. 48:1128–1137. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Grouls C, Hatting M, Rix A, Pochon S,
Lederle W, Tardy I, Kuhl CK, Trautwein C, Kiessling F and Palmowski
M: Liver dysplasia. US molecular imaging with targeted contrast
agent enables early assessment. Radiology. 267:487–495. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ferrante EA, Pickard JE, Rychak J,
Klibanov A and Ley K: Dual targeting improves microbubble contrast
agent adhesion to VCAM-1 and P-selectin under flow. J Control
Release. 140:100–107. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Minhajat R, Mori D, Yamasaki F, Sugita Y,
Satoh T and Tokunaga O: Endoglin (CD105) expression in angiogenesis
of colon cancer: Analysis using tissue microarrays and comparison
with other endothelial markers. Virchows Arch. 448:127–134. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Foygel K, Wang H, Machtaler S, Lutz AM,
Chen R, Pysz M, Lowe AW, Tian L, Carrigan T, Brentnall TA and
Willmann JK: Detection of pancreatic ductal adenocarcinoma in mice
by ultrasound imaging of thymocyte differentiation antigen 1.
Gastroenterology. 145(885–894): e32013.
|
|
35
|
Tian H, Mythreye K, Golzio C, Katsanis N
and Blobe GC: Endoglin mediates fibronectin/alpha5beta1 integrin
and TGF-beta pathway crosstalk in endothelial cells. EMBO J.
31:3885–3900. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Park S, Sorenson CM and Sheibani N:
PECAM-1 isoforms, eNOS and endoglin axis in regulation of
angiogenesis. Clin Sci (Lond). 129:217–234. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Bzyl J, Lederle W, Rix A, Grouls C, Tardy
I, Pochon S, Siepmann M, Penzkofer T, Schneider M, Kiessling F and
Palmowski M: Molecular and functional ultrasound imaging in
differently aggressive breast cancer xenografts using two novel
ultrasound contrast agents (BR55 and BR38). Eur Radiol.
21:1988–1995. 2011. View Article : Google Scholar : PubMed/NCBI
|
